Schrodinger (SDGR) vs First Tracks Biotherapeutics (TRAX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
First Tracks Biotherapeutics is the larger company by market cap ($1.75 billion vs $1.72 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SDGR | TRAX |
|---|---|---|
| Share price | $22.93 | $41.64 |
| Market cap | $1.72B | $1.75B |
| 1-day change | -12.95% | -6.34% |
| YTD return | +28.24% | — |
| 1-year return | +39.22% | — |
| 5-year return | -42.01% | — |
| EPS (TTM) | $-0.79 | $-4.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $255.87M | — |
| Revenue growth (YoY) | +23.29% | — |
| Net income (latest FY) | $-103.27M | — |
| Gross margin | 55.74% | — |
| Operating margin | -65.23% | — |
| Net margin | -40.36% | — |
| 52-week high | $34.00 | $54.78 |
| 52-week low | $10.95 | $14.72 |
| Distance from 52-week high | -32.56% | -23.99% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +46.40% | +80.52% |
| Average volume | 2.08M | 826.70K |
| Shares outstanding | 65.91M | 42.02M |
| Employees | 850 | 104 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Schrodinger
SDGR stock →Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery.
Health Care · Biotechnology: Pharmaceutical Preparations · 850 employees
About First Tracks Biotherapeutics
TRAX stock →First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 104 employees
SDGR vs TRAX FAQ
Which is bigger, Schrodinger or First Tracks Biotherapeutics?
First Tracks Biotherapeutics (TRAX) is larger, with a market capitalization of $1.75B compared with $1.72B for Schrodinger (SDGR).
Are Schrodinger and First Tracks Biotherapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.